Vasoactive Intestinal Peptide-Positive (VIP+) Interneurons describes a neural cell population with specific vulnerability or functional significance in neurodegenerative disease. This page covers cell morphology, molecular markers, connectivity, and disease-specific pathological changes.
Vasoactive intestinal peptide-positive (VIP+) interneurons are a specialized class of cortical GABAergic neurons that comprise approximately 10-15% of cortical interneurons. Unlike PV+ and SST+ interneurons that directly inhibit pyramidal cells, VIP+ interneurons primarily target other interneurons—particularly SST+ Martinotti cells—creating a disinhibitory circuit that is crucial for attention, arousal, and top-down processing. Their unique role in gating dendritic inhibition makes them essential for cognitive flexibility and vulnerable in neurodegenerative diseases.
| Taxonomy |
ID |
Name / Label |
| Cell Ontology (CL) |
CL:0002269 |
vasoactive intestinal peptide secreting cell |
- Parent Classification: Cortical interneuron
- Full Lineage: Neuron > GABAergic > Cortical interneuron > VIP+
- Brain Regions: Cerebral cortex (layers 2/3), Hippocampus
¶ Molecular Identity and Markers
- Vasoactive Intestinal Peptide (VIP): 28-amino acid neuropeptide with neuromodulatory functions
- Calretinin: Calcium-binding protein co-expressed in 70-80% of VIP+ cells
- Cholecystokinin (CCK): Co-expressed in subset of VIP+ neurons
- Substance P: Occasional co-expression in specific subtypes
- Dbx1: Dorsal progenitor origin marker (caudal ganglionic eminence)
- COUP-TFII: Specifies VIP+ interneuron lineage
- Prox1: Present in CGE-derived interneurons
- Sp8: Transcription factor for VIP+ specification
¶ Ion Channels and Receptors
- 5-HT3A Receptors: Serotonin-gated ion channel (diagnostic marker)
- α7 Nicotinic Receptors: Cholinergic modulation
- Cholinergic Muscarinic Receptors: M1/M2 for arousal modulation
- NMDA/AMPA Receptors: Glutamatergic excitation
- GAD65/GAD67: GABA synthesis enzymes
- VGAT: Vesicular GABA transporter
- GABA-A Receptor Subunits: α1, β2/3, γ2 on target cells
- Dendrites: Vertically oriented, spanning multiple layers
- Axons: Local ramification with some long-range projections
- Distribution: Layers 2-6, most common in layers 2/3
- Dendrites: Radial orientation
- Axons: Dense local plexus
- Distribution: All cortical layers
- Characteristics: Axons restricted to layer 1
- Function: Modulate distal dendritic activity
- Distribution: Superficial layers
- Projections: Extend across cortical areas
- Function: Interareal coordination of disinhibition
- Distribution: Deeper cortical layers
- Irregular Spiking: Interspike interval variability
- Adapting: Frequency adaptation during sustained firing
- Burst Firing: Some VIP+ neurons exhibit bursting
- Late Spiking: Delayed action potential onset in some subtypes
- Resting Potential: -55 to -60 mV (relatively depolarized)
- Input Resistance: High (300-500 MΩ)
- Rheobase: Low threshold for activation
- Sag: Prominent H-current-mediated sag during hyperpolarization
- Weak Inhibition: Smaller IPSCs than PV+ or SST+ neurons
- Paired-Pulse Facilitation: Common at VIP terminals
- Volume Transmission: Possible extrasynaptic GABA release
flowchart TD
ACH["Basal Forebrain\n(Acetylcholine)"] --> VIP["VIP+ Interneurons\n(Layers 2/3)"]
SER["Raphe Nuclei\n(Serotonin via 5-HT3A)"] --> VIP
NE["Locus Coeruleus\n(Norepinephrine)"] --> VIP
VIP -->|"Inhibits"| SST["SST+ Martinotti Cells"]
SST -.->|"Normally Inhibits\nDendrites"| PYR["Pyramidal Neuron\nDendrites"]
VIP -->|"Disinhibition:\nSST Inhibition Removed"| PYR
PYR --> OUT["Enhanced Dendritic\nIntegration and Plasticity"]
OUT --> COG["Attention, Arousal,\nCognitive Flexibility"]
Disinhibition Mechanism:
- Top-down signals (acetylcholine from basal forebrain, serotonin from raphe, norepinephrine from LC) activate VIP+ interneurons
- VIP+ neurons inhibit SST+ Martinotti cells
- SST+ inhibition of pyramidal dendrites is reduced
- Result: Enhanced dendritic integration and plasticity
¶ Attention and Arousal
Cholinergic Modulation:
- Basal forebrain cholinergic input activates VIP+ neurons
- VIP+ disinhibition enables attentional selection
- VIP+ activity increases during focused attention tasks
Noradrenergic Modulation:
- Locus coeruleus input enhances VIP+ excitability
- Arousal-related network reconfiguration via VIP+ cells
- Wakefulness-associated disinhibitory tone
- Active Processing: VIP+ neurons highly active, dendritic disinhibition
- Quiet Wakefulness: Reduced VIP activity, balanced inhibition
- Sleep: VIP+ activity suppressed, enhanced SST+ dendritic inhibition
¶ Social and Emotional Processing
- Default Mode Network: VIP+ modulation of DMN activity
- Social Cognition: Disinhibitory control in social circuits
- Emotional Regulation: VIP+ neurons in amygdala circuits
Cholinergic Hypothesis Connection:
- VIP+ interneurons are primary targets of cholinergic input
- Basal forebrain degeneration → loss of VIP+ activation
- Impaired attention and arousal in AD
Disinhibitory Circuit Disruption:
- Reduced VIP+ function leads to excessive SST+ inhibition
- Dendritic processing deficits in hippocampus
- Memory encoding impairment
VIP Neuroprotective Effects:
- VIP has anti-inflammatory and neuroprotective properties
- VIP receptors (VPAC1/2) protect against Aβ toxicity
- Reduced VIP levels in AD brain
Dopamine-ACh Interactions:
- Dopamine modulates cholinergic interneurons
- PD dopamine loss affects VIP+ neuron activation
- Attention deficits in PD linked to VIP+ dysfunction
Cognitive Symptoms:
- Impaired VIP+ function contributes to executive dysfunction
- Reduced cognitive flexibility from disinhibitory circuit disruption
- Attention and working memory deficits
Behavioral Variant FTD:
- VIP+ interneuron loss in frontal and temporal cortex
- Impaired social disinhibition circuits
- Loss of behavioral flexibility
C9orf72 Expansion:
- VIP+ neurons vulnerable to C9orf72-mediated toxicity
- Dipeptide repeat proteins affect VIP+ function
Striatal VIP+ Interneurons:
- Small population but functionally important
- Vulnerable to mutant huntingtin
- Contribute to movement and cognitive symptoms
Cortical Inhibition Changes:
- Limited data on VIP+ neurons in ALS
- Potential compensatory changes in disinhibitory circuits
- May contribute to motor cortex hyperexcitability
| Compound |
Target |
Application |
| Aviptadil |
VPAC1/2 |
Neuroprotection trials |
| Ro 25-1553 |
VPAC2 |
Cognitive enhancement |
| BAY 55-9837 |
VPAC2 |
Anti-inflammatory |
| Lys15, Arg16, Lys27VIP(1-7) |
VPAC1 |
Specific agonist |
- Acetylcholinesterase Inhibitors: Donepezil, rivastigmine for AD
- Alpha-7 Nicotinic Agonists: Enhance VIP+ activation
- Muscarinic Modulators: M1 positive allosteric modulators
- 5-HT3 Agonists: Direct VIP+ activation
- SSRIs: Indirect enhancement via 5-HT availability
- Psilocybin/5-HT2A: Potential VIP+ circuit modulation
- VIP Gene Therapy: AAV-mediated VIP expression
- Anti-inflammatory: Reduce neuroinflammation affecting VIP+ cells
- Mitochondrial Support: Protect VIP+ neurons from energy deficits
¶ Biomarkers and Diagnostics
- Reduced in AD and other dementias
- Correlation with cognitive decline
- Potential therapeutic target
- GABA-MRS: Indirect VIP+ function assessment
- Functional connectivity: Disinhibitory network integrity
- PET: VIP receptor ligand development
- EEG gamma power: Reflects VIP-PV circuit function
- Attention-related potentials: VIP+ circuit biomarkers
- Sleep architecture: VIP+ modulation of sleep states